JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 44(2010) N 4 p. 633-641;
S.P. Korolev1*, V.N. Tashlitskii1, M.A. Smolov1, A.V. Gromyko2, A.L. Zhuze2, J.J. Agapkina1, M.B. Gottikh1

HIV-1 Integrase Inhibition by Dimeric Bis-Benzimidazoles with Different Spacer Structures

1Department of Chemistry and Belozersky Institute of Physicochemical Biology, Moscow State University, Moscow, 119991, Russia
2Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia

*spkorolev@mail.ru
Received - 2010-02-25; Accepted - 2010-03-19

HIV-1 integrase is responsible for one of the key stages in virus replication, namely, integration of viral cDNA into the host cell genome. Integration inhibition leads to a complete block of the virus replication. We studied the integration inhibition by dimeric bis-benzimidazoles DBBI(7) with heptamethylene and DBBI(8) with tri(ethylene glycol) spacers and found that IC50 for DBBI(7) was approximately 0.03 μM and for DBBI(8) it was approximately 10 μM. Crosslinking assays demonstrated that both compounds interfered with a proper positioning of the DNA substrate in the active centre of integrase. To clarify the inhibition mechanism, dissociation constants were determined for the complexes between DBBI and integrase DNA substrate. Calculated Kd values for the complexes formed by DBBI(7) and DBBI(8) were 270 and 140 nM, respectively. Thus, the integration inhibition is not directly connected with DBBI binding to DNA. The dependence of initial enzymatic reaction rate on DNA substrate concentration in the presence of different concentrations of inhibitors was found, and inhibition constants were determined. These data suggest that different inhibition activity of DBBI(7) and DBBI (8) is determined by different mechanisms underlying their action, namely, competitive inhibition of integrase by DBBI(7) and a composite mechanism assumed for DBBI(8).

HIV-1 integrase, dimeric bis-benzimidazoles, mechanism of inhibition



JMB-FOOTER RAS-JOURNALS